Analysis of dose response of trinitrochlorobenzene contact hypersensitivity induction in mice: Pretreatment with cyclophosphamide reveals an optimal sensitizing dose

Sabra Sullivan, Paul R. Bergstresser, J. Wayne Streilein

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A detailed dose-response curve has been established for induction of contact hypersensitivity (CH) in mice with trinitrochlorobenzene (TNCB). It was determined that in BALB/c, CBA/J, and C57BL/6 mice, the dose required to sensitize via epicutaneous application was between 1 and 10,μg TNCB. When doses of hapten of 200,μg or greater were painted on abdominal skin, CH responses were induced which were only marginally greater than responses induced by sensitizing doses of hapten in the 10-50-μg range, implying that no further dose-response relationship exists beyond 50 μg of hapten. However, in companion experiments, in which panels of mice were pretreated with cyclophosphamide, it was determined that sensitizing doses of hapten in excess of 50 μg induced both CH and concomitant induction of down-regulation of CH. Thus, at 200 μg or higher doses of TNCB, CH responses of cyclophosphamide pretreated mice were invariably more intense than in their untreated, hapten-painted cohorts. In the animals pretreated with cyclophosphamide, it was possible to see that a dose-response relationship continued to exist between the amount of epicutaneously applied hapten over a 200 μg to 14 mg range and the intensity of the CH induced. We conclude that the optimal dose for immunizing mice epicutaneously with TNCB is between 10 and 50,μg. This is considered optimal since animals sensitized in this manner display no evidence of concomitant down-regulation of their CH responses.

Original languageEnglish (US)
Pages (from-to)711-716
Number of pages6
JournalJournal of Investigative Dermatology
Volume94
Issue number5
StatePublished - May 1990

Fingerprint

Picryl Chloride
Haptens
Contact Dermatitis
Cyclophosphamide
Animals
Down-Regulation
Inbred C57BL Mouse
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Analysis of dose response of trinitrochlorobenzene contact hypersensitivity induction in mice : Pretreatment with cyclophosphamide reveals an optimal sensitizing dose. / Sullivan, Sabra; Bergstresser, Paul R.; Streilein, J. Wayne.

In: Journal of Investigative Dermatology, Vol. 94, No. 5, 05.1990, p. 711-716.

Research output: Contribution to journalArticle

@article{2fbd589b5a264c8893e5faa22b22994e,
title = "Analysis of dose response of trinitrochlorobenzene contact hypersensitivity induction in mice: Pretreatment with cyclophosphamide reveals an optimal sensitizing dose",
abstract = "A detailed dose-response curve has been established for induction of contact hypersensitivity (CH) in mice with trinitrochlorobenzene (TNCB). It was determined that in BALB/c, CBA/J, and C57BL/6 mice, the dose required to sensitize via epicutaneous application was between 1 and 10,μg TNCB. When doses of hapten of 200,μg or greater were painted on abdominal skin, CH responses were induced which were only marginally greater than responses induced by sensitizing doses of hapten in the 10-50-μg range, implying that no further dose-response relationship exists beyond 50 μg of hapten. However, in companion experiments, in which panels of mice were pretreated with cyclophosphamide, it was determined that sensitizing doses of hapten in excess of 50 μg induced both CH and concomitant induction of down-regulation of CH. Thus, at 200 μg or higher doses of TNCB, CH responses of cyclophosphamide pretreated mice were invariably more intense than in their untreated, hapten-painted cohorts. In the animals pretreated with cyclophosphamide, it was possible to see that a dose-response relationship continued to exist between the amount of epicutaneously applied hapten over a 200 μg to 14 mg range and the intensity of the CH induced. We conclude that the optimal dose for immunizing mice epicutaneously with TNCB is between 10 and 50,μg. This is considered optimal since animals sensitized in this manner display no evidence of concomitant down-regulation of their CH responses.",
author = "Sabra Sullivan and Bergstresser, {Paul R.} and Streilein, {J. Wayne}",
year = "1990",
month = "5",
language = "English (US)",
volume = "94",
pages = "711--716",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Analysis of dose response of trinitrochlorobenzene contact hypersensitivity induction in mice

T2 - Pretreatment with cyclophosphamide reveals an optimal sensitizing dose

AU - Sullivan, Sabra

AU - Bergstresser, Paul R.

AU - Streilein, J. Wayne

PY - 1990/5

Y1 - 1990/5

N2 - A detailed dose-response curve has been established for induction of contact hypersensitivity (CH) in mice with trinitrochlorobenzene (TNCB). It was determined that in BALB/c, CBA/J, and C57BL/6 mice, the dose required to sensitize via epicutaneous application was between 1 and 10,μg TNCB. When doses of hapten of 200,μg or greater were painted on abdominal skin, CH responses were induced which were only marginally greater than responses induced by sensitizing doses of hapten in the 10-50-μg range, implying that no further dose-response relationship exists beyond 50 μg of hapten. However, in companion experiments, in which panels of mice were pretreated with cyclophosphamide, it was determined that sensitizing doses of hapten in excess of 50 μg induced both CH and concomitant induction of down-regulation of CH. Thus, at 200 μg or higher doses of TNCB, CH responses of cyclophosphamide pretreated mice were invariably more intense than in their untreated, hapten-painted cohorts. In the animals pretreated with cyclophosphamide, it was possible to see that a dose-response relationship continued to exist between the amount of epicutaneously applied hapten over a 200 μg to 14 mg range and the intensity of the CH induced. We conclude that the optimal dose for immunizing mice epicutaneously with TNCB is between 10 and 50,μg. This is considered optimal since animals sensitized in this manner display no evidence of concomitant down-regulation of their CH responses.

AB - A detailed dose-response curve has been established for induction of contact hypersensitivity (CH) in mice with trinitrochlorobenzene (TNCB). It was determined that in BALB/c, CBA/J, and C57BL/6 mice, the dose required to sensitize via epicutaneous application was between 1 and 10,μg TNCB. When doses of hapten of 200,μg or greater were painted on abdominal skin, CH responses were induced which were only marginally greater than responses induced by sensitizing doses of hapten in the 10-50-μg range, implying that no further dose-response relationship exists beyond 50 μg of hapten. However, in companion experiments, in which panels of mice were pretreated with cyclophosphamide, it was determined that sensitizing doses of hapten in excess of 50 μg induced both CH and concomitant induction of down-regulation of CH. Thus, at 200 μg or higher doses of TNCB, CH responses of cyclophosphamide pretreated mice were invariably more intense than in their untreated, hapten-painted cohorts. In the animals pretreated with cyclophosphamide, it was possible to see that a dose-response relationship continued to exist between the amount of epicutaneously applied hapten over a 200 μg to 14 mg range and the intensity of the CH induced. We conclude that the optimal dose for immunizing mice epicutaneously with TNCB is between 10 and 50,μg. This is considered optimal since animals sensitized in this manner display no evidence of concomitant down-regulation of their CH responses.

UR - http://www.scopus.com/inward/record.url?scp=0025344343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025344343&partnerID=8YFLogxK

M3 - Article

C2 - 2324526

AN - SCOPUS:0025344343

VL - 94

SP - 711

EP - 716

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -